Childhood Cancer Incidence, New York City, 2005-2009
Source: New York State Cancer Registry
| Site of Cancer | Ages 0-4 | Ages 5-9 | Ages 10-14 | Ages 15-19 | Combined Ages 0-14 | Combined Ages 0-19 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | 95% CI (+/-) | Avg Annual Cases | Rate per 1,000,000 | 95% CI (+/-) | |
| All Invasive Malignant Tumors | 120.6 | 210.1 | 63.4 | 125.3 | 83.0 | 166.0 | 126.2 | 242.6 | 267.0 | 166.3 | 9.0 | 393.2 | 185.5 | 8.2 |
| I Leukemias | 42.4 | 73.9 | 20.8 | 41.1 | 19.4 | 38.8 | 21.8 | 41.9 | 82.6 | 50.9 | 4.9 | 104.4 | 48.7 | 4.2 |
| I(a) Lymphoid leukemias | 30.4 | 53.0 | 16.4 | 32.4 | 12.0 | 24.0 | 11.0 | 21.1 | 58.8 | 36.3 | 4.2 | 69.8 | 32.5 | 3.4 |
| I(b) Acute myeloid leukemia | 6.0 | 10.5 | 1.6 | 3.2 | 4.4 | 8.8 | 4.6 | 8.8 | 12.0 | 7.4 | 1.9 | 16.6 | 7.8 | 1.7 |
| II Lymphomas and reticuloendothelial neoplasms | 6.0 | 10.5 | 7.4 | 14.6 | 18.6 | 37.2 | 31.2 | 60.0 | 32.0 | 21.0 | 3.3 | 63.2 | 30.8 | 3.4 |
| II(a) Hodgkin lymphoma | 0.2 | 0.3 | 2.6 | 5.1 | 9.4 | 18.8 | 18.4 | 35.4 | 12.2 | 8.2 | 2.1 | 30.6 | 15.1 | 2.4 |
| II(b,c,d) Non-Hodgkin lymphomas | 5.8 | 10.1 | 4.6 | 9.1 | 9.0 | 18.0 | 12.6 | 24.2 | 19.4 | 12.5 | 2.5 | 32.0 | 15.4 | 2.4 |
| III CNS & misc intracranial & intraspinal neoplasms | 17.4 | 30.3 | 20.2 | 39.9 | 14.0 | 28.0 | 11.4 | 21.9 | 51.6 | 32.8 | 4.0 | 63.0 | 30.1 | 3.3 |
| III(a) Ependymomas and choroid plexus tumor | 2.8 | 4.9 | 1.2 | 2.4 | 0.8 | 1.6 | 0.6 | 1.2 | 4.8 | 2.9 | 1.2 | 5.4 | 2.5 | 0.9 |
| III(b) Astrocytoma | 7.0 | 12.2 | 9.6 | 19.0 | 8.4 | 16.8 | 6.0 | 11.5 | 25.0 | 16.1 | 2.8 | 31.0 | 14.9 | 2.4 |
| III(c) Intracranial and intraspinal embryonal tum | 4.8 | 8.4 | 5.8 | 11.5 | 1.4 | 2.8 | 1.2 | 2.3 | 12.0 | 7.5 | 1.9 | 13.2 | 6.2 | 1.5 |
| III(d) Other gliomas | 2.6 | 4.5 | 3.6 | 7.1 | 2.8 | 5.6 | 3.0 | 5.8 | 9.0 | 5.8 | 1.7 | 12.0 | 5.8 | 1.5 |
| IV Neuroblastoma and other peripheral nervous cell tumors | 16.2 | 28.2 | 1.6 | 3.2 | 1.0 | 2.0 | 0.6 | 1.2 | 18.8 | 10.7 | 2.2 | 19.4 | 8.3 | 1.7 |
| IV(a) Neuroblastoma and ganglioneuroblastoma | 16.2 | 28.2 | 1.4 | 2.8 | 0.6 | 1.2 | 0.6 | 1.2 | 18.2 | 10.3 | 2.1 | 18.8 | 8.0 | 1.6 |
| V Retinoblastoma | 7.8 | 13.6 | 0.2 | 0.4 | 0.0 | 0.0 | 0.2 | 0.4 | 8.0 | 4.5 | 1.4 | 8.2 | 3.5 | 1.1 |
| VI Renal tumors | 12.0 | 20.9 | 1.6 | 3.2 | 1.4 | 2.8 | 2.0 | 3.8 | 15.0 | 8.8 | 2.0 | 17.0 | 7.5 | 1.6 |
| VI(a) Nephroblastoma and other nonepithelial rena | 12.0 | 20.9 | 1.2 | 2.4 | 0.2 | 0.4 | 0.2 | 0.4 | 13.4 | 7.7 | 1.8 | 13.6 | 5.9 | 1.4 |
| VII Hepatic tumors | 4.6 | 8.0 | 0.0 | 0.0 | 1.0 | 2.0 | 0.8 | 1.5 | 5.6 | 3.2 | 1.2 | 6.4 | 2.8 | 1.0 |
| VII(a) Hepatoblastoma | 4.6 | 8.0 | 0.0 | 0.0 | 0.2 | 0.4 | 0.0 | 0.0 | 4.8 | 2.7 | 1.1 | 4.8 | 2.0 | 0.8 |
| VIII Malignant bone tumors | 1.4 | 2.4 | 3.2 | 6.3 | 9.6 | 19.2 | 8.6 | 16.5 | 14.2 | 9.5 | 2.2 | 22.8 | 11.2 | 2.1 |
| VIII(a) Osteosarcoma | 0.2 | 0.3 | 2.2 | 4.3 | 6.6 | 13.2 | 6.4 | 12.3 | 9.0 | 6.1 | 1.8 | 15.4 | 7.6 | 1.7 |
| VIII(c) Ewing tumor and related sarcomas of bone | 1.0 | 1.7 | 0.6 | 1.2 | 1.2 | 2.4 | 1.2 | 2.3 | 2.8 | 1.8 | 0.9 | 4.0 | 1.9 | 0.8 |
| IX Soft tissue and other extraosseous sarcomas | 7.6 | 13.2 | 4.0 | 7.9 | 5.8 | 11.6 | 11.2 | 21.5 | 17.4 | 10.8 | 2.3 | 28.6 | 13.5 | 2.2 |
| IX(a) Rhabdomyosarcoma | 4.8 | 8.4 | 2.0 | 4.0 | 1.8 | 3.6 | 1.6 | 3.1 | 8.6 | 5.2 | 1.6 | 10.2 | 4.7 | 1.3 |
| X Germ cell & trophoblastic tumors & gonadal neoplasms | 3.8 | 6.6 | 1.8 | 3.6 | 3.6 | 7.2 | 14.4 | 27.7 | 9.2 | 5.7 | 1.7 | 23.6 | 11.3 | 2.0 |
| X(a) Intracranial and intraspinal germ cell tumo | 0.4 | 0.7 | 0.6 | 1.2 | 1.0 | 2.0 | 1.6 | 3.1 | 2.0 | 1.3 | 0.8 | 3.6 | 1.7 | 0.8 |
| X(c) Malignant gonadal germ cell tumor | 1.4 | 2.4 | 1.2 | 2.4 | 2.4 | 4.8 | 9.4 | 18.1 | 5.0 | 3.2 | 1.3 | 14.4 | 6.9 | 1.6 |
| XI Other malignant epithelial neoplasms and malignant melanomas | 0.8 | 1.4 | 2.6 | 5.1 | 8.2 | 16.4 | 23.8 | 45.7 | 11.6 | 7.8 | 2.0 | 35.4 | 17.3 | 2.6 |
| XI(b) Thyroid carcinoma | 0.0 | 0.0 | 1.2 | 2.4 | 3.4 | 6.8 | 12.6 | 24.2 | 4.6 | 3.1 | 1.3 | 17.2 | 8.4 | 1.8 |
| XI(d) Malignant melanoma | 0.2 | 0.3 | 0.6 | 1.2 | 1.0 | 2.0 | 3.2 | 6.2 | 1.8 | 1.2 | 0.8 | 5.0 | 2.4 | 1.0 |
| XII Other and unspecified malignant neoplasms | 0.6 | 1.0 | 0.0 | 0.0 | 0.4 | 0.8 | 0.2 | 0.4 | 1.0 | 0.6 | 0.5 | 1.2 | 0.6 | 0.4 |
Notes
- Incidence data are provisional, November 2011.
- Rates are per 1,000,000 children. Rates for 0-14 and 0-19 year age intervals are age-adjusted within these intervals to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution.
- Non-Hodgkin lymphomas, Burkitt, and miscellaneous lymphomas are grouped together under II(b,c,d).
